| |
|
|
|
Arcadia Biosciences Inc.  
|
|
6.14 0.21 (0.04%) |
04-22 16:00 |
|
Open: |
5.92 |
Pre close: |
5.93 |
Target:
|
8.27 
|
|
High: |
6.16 |
Low: |
5.92 |
Resistance:
|
7.08
7.83
|
|
Volume: |
111,790 |
Market Cap: |
29M |
Support:
|
5.86
4.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.06
|
MACD |
MACD(12,26):
|
-0.16 |
|
MA(20): |
6.70 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
5.09  |
Stochastic Oscillator |
%K(14,3):
|
8.51 |
|
MA(250): |
6.25 |
%D(3): |
7.48 |
|
Average Volume(K) |
3-Month: |
94799
|
52-Week |
High:
|
18.40 |
|
10-Days: |
12345 |
Low: |
2.64 |
|
RSI |
RSI(14):
|
42.33 |
Change(%): |
-69.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-7.480 |
Return on Equity (ttm) |
-131.6 |
Shares Out. (M) |
4.78 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-67.6 |
Shares Float (M) |
4.63 |
|
EPS Est. Next Year |
-0.220 |
PEG Ratio |
-0.18 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
-68.9 |
% Held by Institutions |
7.30 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.650 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.82 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.32 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.63 |
P/S |
75254352.00 |
|
Operating Margin |
-1152.32 |
Levered Free Cash Flow
(M) |
-8.58 |
P/CF |
-2.15 |
|
|
|
|
|
|
